ALKBH5 and Alzheimer disease: Similarly, by reducing the level of DDX6 (Figures 8J,K), we found that DDX6 knockdown also partially neutralized the role of ALKBH5 overexpression in the progression of AD in vitro and in vivo (Figures 8L–P and Supplementary Figure 7F).